Role and timing of new drugs in CLL

Hematol Oncol. 2017 Jun;35 Suppl 1:30-32. doi: 10.1002/hon.2397.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Disease-Free Survival
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Leukemia, Lymphocytic, Chronic, B-Cell / mortality*
  • Risk Factors
  • Survival Rate
  • Time Factors

Substances

  • Antineoplastic Agents